News for hackers. Stuff that matters.
Re:Compass Pathways' Phase IIb psilocybin trial shows reduce... by rory on Wednesday November 10, 2021 @11:31AM (#29176587)
21% delta in remission rate vs. placebo is higher than both SSRIs and bupropion in this study [0] for example (11% for both). This is also a single dose which is amazing.

[0] https://pubmed.ncbi.nlm.nih.gov/16086611/

There are no comments on this comment yet.